Therefore, the present study analyzed CD14+HLA-DRlow/− MDSCs from 49 CLL patients, monoclonal B-cell lymphocytosis (MBL) patients and healthy volunteers. This evidence concerns the gene CD14 and B-cell chronic lymphocytic leukemia.